BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 34360654)

  • 21. Expression of Granulysin and FOXP3 in Cutaneous T Cell Lymphoma and Sézary Syndrome.
    Shareef MM; Elgarhy LH; Wasfy Rel-S
    Asian Pac J Cancer Prev; 2015; 16(13):5359-64. PubMed ID: 26225678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of clonal T-cell receptor gamma gene rearrangements in early mycosis fungoides/Sezary syndrome by polymerase chain reaction and denaturing gradient gel electrophoresis (PCR/DGGE).
    Wood GS; Tung RM; Haeffner AC; Crooks CF; Liao S; Orozco R; Veelken H; Kadin ME; Koh H; Heald P
    J Invest Dermatol; 1994 Jul; 103(1):34-41. PubMed ID: 8027579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD147 stimulates hepatoma cells escaping from immune surveillance of T cells by interaction with Cyclophilin A.
    Ren YX; Wang SJ; Fan JH; Sun SJ; Li X; Padhiar AA; Zhang JN
    Biomed Pharmacother; 2016 May; 80():289-297. PubMed ID: 27133068
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mycosis fungoides/Sézary syndrome: report of an unusual case.
    Mehta A; Dhungel BM; Khan MF
    J Cutan Pathol; 2006 Sep; 33 Suppl 2():12-5. PubMed ID: 16972946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IRF4 gene rearrangements define a subgroup of CD30-positive cutaneous T-cell lymphoma: a study of 54 cases.
    Pham-Ledard A; Prochazkova-Carlotti M; Laharanne E; Vergier B; Jouary T; Beylot-Barry M; Merlio JP
    J Invest Dermatol; 2010 Mar; 130(3):816-25. PubMed ID: 19812605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T-cell receptor gamma gene rearrangement by multiplex polymerase chain reaction/heteroduplex analysis in patients with cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome) and benign inflammatory disease: correlation with clinical, histological and immunophenotypical findings.
    Ponti R; Quaglino P; Novelli M; Fierro MT; Comessatti A; Peroni A; Bonello L; Bernengo MG
    Br J Dermatol; 2005 Sep; 153(3):565-73. PubMed ID: 16120144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A histo-immunopathologic and prognostic study of erythrodermic cutaneous T-cell lymphoma.
    Vonderheid EC; Kantor GR; Telang GH; Bujanouskas P; Kadin ME
    J Cutan Pathol; 2019 Dec; 46(12):913-924. PubMed ID: 31403211
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IL-15 and IL-17F are differentially regulated and expressed in mycosis fungoides (MF).
    Willerslev-Olsen A; Litvinov IV; Fredholm SM; Petersen DL; Sibbesen NA; Gniadecki R; Zhang Q; Bonefeld CM; Wasik MA; Geisler C; Zhou Y; Woetmann A; Sasseville D; Krejsgaard T; Odum N
    Cell Cycle; 2014; 13(8):1306-12. PubMed ID: 24621498
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Understanding Cell Lines, Patient-Derived Xenograft and Genetically Engineered Mouse Models Used to Study Cutaneous T-Cell Lymphoma.
    Gill RPK; Gantchev J; Martínez Villarreal A; Ramchatesingh B; Netchiporouk E; Akilov OE; Ødum N; Gniadecki R; Koralov SB; Litvinov IV
    Cells; 2022 Feb; 11(4):. PubMed ID: 35203244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Placental Growth Factor and Vascular Endothelial Growth Factor Together Regulate Tumour Progression via Increased Vasculature in Cutaneous T-cell Lymphoma.
    Miyagaki T; Sugaya M; Oka T; Takahashi N; Kawaguchi M; Suga H; Fujita H; Yoshizaki A; Asano Y; Sato S
    Acta Derm Venereol; 2017 May; 97(5):586-592. PubMed ID: 28119994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression and activity of IL-17 in cutaneous T-cell lymphomas (mycosis fungoides and Sezary syndrome).
    Cirée A; Michel L; Camilleri-Bröet S; Jean Louis F; Oster M; Flageul B; Senet P; Fossiez F; Fridman WH; Bachelez H; Tartour E
    Int J Cancer; 2004 Oct; 112(1):113-20. PubMed ID: 15305382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cutaneous T cell lymphomas: mycosis fungoides, Sezary syndrome and HTLV-I-associated adult T cell leukemia (ATL) in Mali, West Africa: a clinical, pathological and immunovirological study of 14 cases and a review of the African ATL cases.
    Fouchard N; Mahe A; Huerre M; Fraitag S; Valensi F; Macintyre E; Sanou F; de The G; Gessain A
    Leukemia; 1998 Apr; 12(4):578-85. PubMed ID: 9557617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of mogamulizumab in patients with Mycosis Fungoides or Sézary syndrome: A multicentre, retrospective, real-world French study.
    Beylot-Barry M; Quereux G; Nardin C; Duval-Modeste AB; Dereure O; Dalac-Rat S; Dobos G; Pham-Ledard A; Ram-Wolff C; D'Incan M; Grange F; Braniste V; Bagot M
    J Eur Acad Dermatol Venereol; 2023 Sep; 37(9):1777-1784. PubMed ID: 37113040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor microenvironment in mycosis fungoides and Sézary syndrome.
    Rubio Gonzalez B; Zain J; Rosen ST; Querfeld C
    Curr Opin Oncol; 2016 Jan; 28(1):88-96. PubMed ID: 26632770
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mycosis fungoides and Sézary syndrome in Japan. Clinicopathologic study of 107 autopsy cases.
    Arai E; Katayama I; Ishihara K
    Pathol Res Pract; 1991 May; 187(4):451-7. PubMed ID: 1876527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA expression in early mycosis fungoides is distinctly different from atopic dermatitis and advanced cutaneous T-cell lymphoma.
    Ralfkiaer U; Lindahl LM; Litman T; Gjerdrum LM; Ahler CB; Gniadecki R; Marstrand T; Fredholm S; Iversen L; Wasik MA; Bonefeld CM; Geisler C; Krejsgaard T; Glue C; Røpke MA; Woetmann A; Skov L; Grønbæk K; Odum N
    Anticancer Res; 2014 Dec; 34(12):7207-17. PubMed ID: 25503151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential expression of programmed death-1 (PD-1) in Sézary syndrome and mycosis fungoides.
    Cetinözman F; Jansen PM; Vermeer MH; Willemze R
    Arch Dermatol; 2012 Dec; 148(12):1379-85. PubMed ID: 23247480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. STAT3-mediated constitutive expression of SOCS-3 in cutaneous T-cell lymphoma.
    Brender C; Nielsen M; Kaltoft K; Mikkelsen G; Zhang Q; Wasik M; Billestrup N; Odum N
    Blood; 2001 Feb; 97(4):1056-62. PubMed ID: 11159537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinicopathological differential diagnosis of mycosis fungoides/Sézary syndrome from the cutaneous type of adult T-cell leukemia/lymphoma].
    Johno M; Ono T
    Nihon Rinsho; 2000 Mar; 58(3):660-4. PubMed ID: 10741142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased interleukin-36γ expression in skin and sera of patients with atopic dermatitis and mycosis fungoides/Sézary syndrome.
    Otobe S; Sugaya M; Nakajima R; Oka T; Takahashi N; Kabasawa M; Miyagaki T; Asano Y; Sato S
    J Dermatol; 2018 Apr; 45(4):468-471. PubMed ID: 29314201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.